Christopher Mutz - Mar 7, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz
Stock symbol
ANIP
Transactions as of
Mar 7, 2023
Transactions value $
-$84,125
Form type
4
Date filed
3/9/2023, 05:48 PM
Previous filing
Apr 4, 2023
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$63.1K -1.43K -3.6% $44.23 38.1K Mar 7, 2023 Direct F1
transaction ANIP Common Stock Tax liability -$21.1K -476 -1.25% $44.23 37.7K Mar 7, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported.